Evidence map›Paper›PMID 31091653›Full record

ArticleInternational journal of molecular sciences2019

Mitochondrial-Derived Vesicles as Candidate Biomarkers in Parkinson's Disease: Rationale, Design and Methods of the EXosomes in PArkiNson Disease (EXPAND) Study.

Anna Picca, Flora Guerra, Riccardo Calvani, Cecilia Bucci, Maria Rita Lo Monaco, Anna Rita Bentivoglio, Francesco Landi, Roberto Bernabei, Emanuele Marzetti

Open access · goldAbstract read
In one paragraph

Article in International journal of molecular sciences, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 52 papers.

0numbers the graph read from it
0cells of the map it votes in
52citing papers in PubMed
8.3field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

52 citing papers in PubMed, 77 citations in OpenAlex.

  1. Review
  2. Review
  3. Review
  4. Review
  5. Review
  6. Review
  7. Review
  8. Review
  9. Article
  10. Review
  11. Review
  12. Review
  13. Review
  14. Article
  15. Review
  16. Mitochondrial-Derived Vesicles: The Good, the Bad, and the Ugly.International journal of molecular sciences · 2023
    Review
  17. Review
  18. Review
  19. Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 3 institutions in 1 country.

Anna PiccaUniversità Cattolica del Sacro Cuore, Institute of Internal Medicine and Geriatrics, 00168 Rome, Italy. anna.picca1@gmail.com.ORCID 0000-0001-7032-3487
Flora GuerraDepartment of Biological and Environmental Sciences and Technologies, University of Salento, 73100 Lecce, Italy. guerraflora@gmail.com.ORCID 0000-0003-3379-7469
Riccardo CalvaniUniversità Cattolica del Sacro Cuore, Institute of Internal Medicine and Geriatrics, 00168 Rome, Italy. riccardo.calvani@gmail.com.ORCID 0000-0001-5472-2365
Cecilia BucciDepartment of Biological and Environmental Sciences and Technologies, University of Salento, 73100 Lecce, Italy. cecilia.bucci@unisalento.it.ORCID 0000-0002-6232-6183
Maria Rita Lo MonacoFondazione Policlinico Universitario "Agostino Gemelli" IRCCS, 00168 Rome, Italy. mariarita.lomonaco@policlinicogemelli.it.
Anna Rita BentivoglioFondazione Policlinico Universitario "Agostino Gemelli" IRCCS, 00168 Rome, Italy. annarita.bentivoglio@unicatt.it.
Francesco LandiUniversità Cattolica del Sacro Cuore, Institute of Internal Medicine and Geriatrics, 00168 Rome, Italy. francesco.landi@unicatt.it.
Roberto BernabeiUniversità Cattolica del Sacro Cuore, Institute of Internal Medicine and Geriatrics, 00168 Rome, Italy. roberto.bernabei@unicatt.it.
Emanuele MarzettiFondazione Policlinico Universitario "Agostino Gemelli" IRCCS, 00168 Rome, Italy. emanuele.marzetti@policlinicogemelli.it.
Università Cattolica del Sacro Cuore · ITAgostino Gemelli University Polyclinic · ITUniversity of Salento · IT

Funding

Associazione Italiana per la Ricerca sul Cancro Investigator Grant 2016 N. 19068Centro Studi "Achille e Linda Lorenzon" N/AInnovative Medicines Initiative 115621Università Cattolica del Sacro Cuore D3.2 2013Università Cattolica del Sacro Cuore D3.2 2015
6 · The paper itself

Abstract

The progressive loss of dopaminergic neurons in the nigro-striatal system is a major trait of Parkinson's disease (PD), manifesting clinically as motor and non-motor symptoms. Mitochondrial dysfunction and oxidative stress are alleged pathogenic mechanisms underlying aggregation of misfolded α-synuclein that in turn triggers dopaminergic neurotoxicity. Peripheral processes, including inflammation, may precede and contribute to neurodegeneration. Whether mitochondrial dyshomeostasis in the central nervous system and systemic inflammation are linked to one another in PD is presently unclear. Extracellular vesicles (EVs) are delivery systems through which cells can communicate or unload noxious materials. EV trafficking also participates in mitochondrial quality control (MQC) by generating mitochondrial-derived vesicles to dispose damaged organelles. Disruption of MQC coupled with abnormal EV secretion may play a role in the pathogenesis of PD. Furthermore, due to its bacterial ancestry, circulating mitochondrial DNA can elicit an inflammatory response. Therefore, purification and characterisation of molecules packaged in, and secreted through, small EVs (sEVs)/exosomes in body fluids may provide meaningful insights into the association between mitochondrial dysfunction and systemic inflammation in PD. The EXosomes in PArkiNson Disease (EXPAND) study was designed to characterise the cargo of sEVs/exosomes isolated from the serum of PD patients and to identify candidate biomarkers for PD.

Indexed as

AgedBiomarkersExosomesFemaleHumansMaleMitochondriaMitophagyParkinson DiseaseBiomarkersexosomesextracellular vesiclesmitochondrial-lysosomal axismitochondrial quality controlmitophagymtDNA

Identifiers

PMID31091653
PMCPMC6566801
OpenAlexW2945139429

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.